Advanced embryonal rhabdomyosarcoma of the uterine cervix: a case report

Background: Primary embryonal rhabdomyosarcoma (RMS) arising from the uterine cervix is a rare and extremely malignant entity. Young women aged 12-26 years are mostly affected. Before the introduction of effective adjuvant chemotherapy, the prognosis of these lesions was poor. Case: A 16-year-old girl presented with vaginal bleeding. The histological examination revealed embryonal RMS of the uterine cervix. The patient was treated with a combination of surgery, chemotherapy and radiotherapy. The patient was alive and free of disease five years after the operation. Conclusion: A combined modality approach to treating RMS using surgery, multidrug chemotherapy, and radiotherapy has significantly improved survival. The medical community should keep in mind that embryonal RMS of the uterine cervix, despite its malignancy and rarity, can be cured if timely and adequate treatment is given.

Advanced; Embryonal rhabdomyosarcoma; Uterine cervix

[1] Robboy S.J. (ed.): “Robboy’s Pathology of the Female Reproductive Tract”. Churchill Livingstone, Elsevier Limited, 2009, 134.

[2] Behtash N., Mousavi A., Tehranian A., Khanafshar N., Hanjani P.: “Embryonal rhabdomyosarcoma of uterine cervix: case report and review of literature”. Gynecol. Oncol., 2003, 91, 452.

[3] Raney R.B., Maurer H.M., Anderson J.R., Andrassey R.J., Donaldson S.S., Qualman S.J. et al.: “The Intergroup Rhabdomyosarcoma Study Group (IRSG): major lessons from the IRS-I through IRS-IV studies as background for the current IRS-V treatment protocols”. Sarcoma, 2001, 5, 9.

[4] Kayton M.L., Wexler L.H., Lewin S.N., Park K.J., La Quaglia

M. P., Abu-Rustum N.R.: “Pediatric radical abdominal trachelectomy for anaplastic embryonal rhabdomyosarcoma of the uterine cervix: an alternative to radical histerectomy”. J. Pediatr. Surg., 2009, 44, 862.

[5] Brand E., Berek J.S., Nieberg R.K., Hacker N.F.: “RMS of the uterine cervix”. Cancer, 1987, 60, 1552.

[6] Vlahos N.P., Matthews R., Veridiano N.P.: “Cervical sarcoma botryoides. A case report”. J. Reprod. Med., 1999, 44, 306.

[7] Daya D.A., Scully R.E.: “Sarcoma Botryoides of the uterine cervix in young woman: a clinicopathological study of 13 cases”. Gynecol. Oncol., 1988, 29, 290.

[8] Wiener E., Wharam M., Vielti T.J., Maurer H.M.: “The third Intergroup RMS study”. J. Clin. Oncol., 1995, 13, 610.

[9] McCluggage W.G., Lioe T.F., McClelland H.R., Lamki H.: “Rhabdomyosarcoma of the uterus: Report of two cases. including one of the spindle cell variant”. Int. J. Gynecol. Cancer, 2002, 12, 128.

[10] Barr F.G.: “Molecular genetics and pathogenesis of rhabdomyosarcoma”. J. Pediatr. Hematol. Oncol., 1997, 19, 483.

[11] Bernal K.L., Fahmy L., Remmenga S., Bridge J., Baker J.: “Embryonal rhabdomyosarcoma (sarcoma botryoides) of the cervix presenting as a cervical polyp treated with fertility.sparing surgery and adjuvant chemotherapy”. Gynecol. Oncol., 2004, 95, 243.

[12] Ballard K.S., Tedjarati S.S., Robinson W.R., Homesley H.D., Thursten R.L.: “Embryonal rhabdomyosarcoma - adjuvant and ex vivo assay-directed chemotherapy”. Int. J. Gynecol. Cancer, 2010, 20, 561.

[13] Porzio G., Toro G., Paris I., Ricevuto E., Ficorella C., Marchetti P.: “Cervical sarcoma botryoides treated with conservative surgery and adjuvant chemotherapy: a case report”. Eur. J. Gynecol. Oncol., 2000, 21, 499.

[14] Atlante M., Dionisi B., Cioni M., Di Ruzza D., Sedati P., Mariani L.: “Sarcoma botryoides of the uterine cervix in a young woman: a case report”. Eur. J. Gynecol. Oncol., 2000, 16, 504.

[15] Gordon A.N., Montag T.W.: “Sarcoma botryoides of the cervix: excision followed by adjuvant chemotherapy for preservation of reproductive function”. Gynecol. Oncol., 1990, 36, 119.